MDT · News · 20261001N
Reimbursement and Payer Mix
Medtronic plc · 2026-10-01 · Importance 44 · Surprise 60 · In source text
The American Medical Association approved new Category I CPT codes for Medtronic's Altaviva implantable tibial neuromodulation device and Symplicity Spyral renal denervation system. The codes replace existing Category III codes and become effective in January 2028. The changes may improve reimbursement and patient access for urge urinary incontinence and uncontrolled hypertension therapies.
Key facts
- The new Category I CPT codes for Altaviva and Symplicity Spyral will replace existing Category III codes and are effective January 2028. source
- The American Medical Association approved new Category I CPT codes for Medtronic's Altaviva implantable tibial neuromodulation device and Symplicity Spyral renal denervation system. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | The new Category I CPT codes for Altaviva and Symplicity Spyral will replace existing Category III codes and are effective January 2028. |